Cost-effectiveness of a quality improvement programme to reduce central line-associated bloodstream infections in intensive care units in the USA

Herzer, K. R., Niessen, Louis ORCID: https://orcid.org/0000-0002-8639-5191, Constenla, D. O., Ward, W. J. and Pronovost, P. J. (2014) 'Cost-effectiveness of a quality improvement programme to reduce central line-associated bloodstream infections in intensive care units in the USA'. BMJ Open, Vol 4, Issue 9, e006065.

Preview

Text BMJ_Open_2014_4_e006065.pdf - Published Version Available under License Creative Commons Attribution Non-commercial. Download (1MB)

Abstract

Objective
To assess the cost-effectiveness of a multifaceted quality improvement programme focused on reducing central line-associated bloodstream infections in intensive care units.

Design
Cost-effectiveness analysis using a decision tree model to compare programme to non-programme intensive care units.

Setting
USA.

Population
Adult patients in the intensive care unit.

Costs
Economic costs of the programme and of central line-associated bloodstream infections were estimated from the perspective of the hospital and presented in 2013 US dollars.

Main outcome measures
Central line-associated bloodstream infections prevented, deaths averted due to central line-associated bloodstream infections prevented, and incremental cost-effectiveness ratios. Probabilistic sensitivity analysis was performed.

Results
Compared with current practice, the programme is strongly dominant and reduces bloodstream infections and deaths at no additional cost. The probabilistic sensitivity analysis showed that there was an almost 80% probability that the programme reduces bloodstream infections and the infections’ economic costs to hospitals. The opportunity cost of a bloodstream infection to a hospital was the most important model parameter in these analyses.

Conclusions
This multifaceted quality improvement programme, as it is currently implemented by hospitals on an increasingly large scale in the USA, likely reduces the economic costs of central line-associated bloodstream infections for US hospitals. Awareness among hospitals about the programme's benefits should enhance implementation. The programme's implementation has the potential to substantially reduce morbidity, mortality and economic costs associated with central line-associated bloodstream infections.

Item Type:	Article
Subjects:	W General Medicine. Health Professions > Health Services. Patients and Patient Advocacy > W 84 Health services. Delivery of health care WA Public Health > WA 30 Socioeconomic factors in public health (General) WC Communicable Diseases > Infection. Bacterial Infections > General Infection > WC 195 Infection. Cross infection. Laboratory infection
Faculty: Department:	Clinical Sciences & International Health > Clinical Sciences Department
Digital Object Identifer (DOI):	https://doi.org/10.1136/bmjopen-2014-006065
Depositing User:	Lynn Roberts-Maloney
Date Deposited:	26 Jan 2015 11:04
Last Modified:	30 Aug 2019 17:25
URI:	https://archive.lstmed.ac.uk/id/eprint/4793

Statistics

View details

Actions (login required)

Edit Item